Latest SR ONE CAPITAL MANAGEMENT, LP Stock Portfolio
$364Million
Equity Portfolio Value
Last Reported on: 13 May, 2024
About SR ONE CAPITAL MANAGEMENT, LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, SR ONE CAPITAL MANAGEMENT, LP reported an equity portfolio of $364.1 Millions as of 31 Mar, 2024.
The top stock holdings of SR ONE CAPITAL MANAGEMENT, LP are ACLX, CRSP, SBTX. The fund has invested 44.8% of it's portfolio in ARCELLX INC and 19.6% of portfolio in CRISPR THERAPEUTICS AG.
They significantly reduced their stock positions in ARCELLX INC (ACLX). SR ONE CAPITAL MANAGEMENT, LP opened new stock positions in CRISPR THERAPEUTICS AG (CRSP). The fund showed a lot of confidence in some stocks as they added substantially to NKARTA INC (NKTX) and MINERALYS THERAPEUTICS INC.
The top stock holdings of SR ONE CAPITAL MANAGEMENT, LP are ACLX, CRSP, SBTX. The fund has invested 44.8% of it's portfolio in ARCELLX INC and 19.6% of portfolio in CRISPR THERAPEUTICS AG.
They significantly reduced their stock positions in ARCELLX INC (ACLX). SR ONE CAPITAL MANAGEMENT, LP opened new stock positions in CRISPR THERAPEUTICS AG (CRSP). The fund showed a lot of confidence in some stocks as they added substantially to NKARTA INC (NKTX) and MINERALYS THERAPEUTICS INC.
New Buys
| Ticker | $ Bought |
|---|---|
| CRISPR THERAPEUTICS AG | 71,496,500 |
New stocks bought by SR ONE CAPITAL MANAGEMENT, LP
Additions
| Ticker | % Inc. |
|---|---|
| NKARTA INC | 150 |
| MINERALYS THERAPEUTICS INC | 12.38 |
Additions to existing portfolio by SR ONE CAPITAL MANAGEMENT, LP
Reductions
| Ticker | % Reduced |
|---|---|
| ARCELLX INC | -25.42 |
SR ONE CAPITAL MANAGEMENT, LP reduced stake in above stock
Sold off
Current Stock Holdings of SR ONE CAPITAL MANAGEMENT, LP
Last Reported on: 13 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 44.83 | 2,346,630 | 163,208,000 | REDUCED | -25.42 | |
| CRSP | CRISPR THERAPEUTICS AG | 19.64 | 1,048,950 | 71,496,500 | NEW | ||
| DSGN | DESIGN THERAPEUTICS INC | 7.22 | 6,526,480 | 26,301,700 | UNCHANGED | 0.00 | |
| NKTX | NKARTA INC | 9.90 | 3,333,330 | 36,033,300 | ADDED | 150 | |
| SBTX | ARS PHARMACEUTICALS INC | 11.26 | 4,012,900 | 41,011,900 | UNCHANGED | 0.00 | |
| MINERALYS THERAPEUTICS INC | 7.15 | 2,016,820 | 26,037,200 | ADDED | 12.38 |